Skip to main content
Tuoxin Pharmaceutical Group Co.,Ltd. logo

Tuoxin Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 301089 ISIN · CNE100004YC3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 734 across all filing types
Latest filing 2025-10-28 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 301089

About Tuoxin Pharmaceutical Group Co.,Ltd.

https://www.tuoxinpharm.com

Tuoxin Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and distribution of nucleosides and nucleotides. The company serves as a major global supplier of active pharmaceutical ingredients (APIs) and chemical intermediates. Its core product portfolio includes cytidine, inosine, guanosine, adenosine, and their various derivatives, which are essential components in the synthesis of antiviral, anti-tumor, and cardiovascular medications. Notably, the group provides key intermediates for drugs such as Ribavirin and Azvudine. Tuoxin Pharmaceutical leverages advanced synthetic biotechnology and large-scale manufacturing capabilities to support the global pharmaceutical industry. The company maintains a focus on technological innovation and quality control to ensure the stability and purity of its chemical products for diverse therapeutic applications.

Recent filings

Filing Released Lang Actions
上市公司独立董事候选人声明与承诺-杨德杰
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes compliance with legal and regulatory requirements, qualifications, and personal commitments related to the role of an independent director. There are no financial statements, earnings data, or report summaries. The content is focused on governance and board member qualifications rather than financial or operational results. This type of document is typically classified under Board/Management Information (MANG) as it relates to board member nominations and declarations.
2025-10-28 Chinese
上市公司独立董事候选人声明与承诺-董红杰
Board/Management Information Classification · 95% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes compliance with legal and regulatory requirements, qualifications, and independence criteria for the role of an independent director. There is no financial data, no report of financial performance, no voting results, no management changes, no earnings or capital updates, and no mention of any meeting or report publication. The document is a formal statement related to governance and compliance for board membership. This fits best under Board/Management Information (MANG), as it concerns the nomination and qualifications of a board member candidate.
2025-10-28 Chinese
上市公司独立董事提名人声明与承诺-杨德杰
Board/Management Information Classification · 95% confidence The document is a formal statement and commitment by a nominator regarding the nomination of an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and independence criteria for the nominee. There is no financial data, earnings information, or report publication mentioned. The content is related to board/management information, specifically about the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 4304 characters, which is relatively short but contains substantive content about board nomination rather than a mere announcement or certification.
2025-10-28 Chinese
关于独立董事任期届满辞职暨补选独立董事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of independent directors due to term expiration and the election of new independent directors. It includes details about the outgoing and incoming directors, their qualifications, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes, specifically about directors' appointments and resignations. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 2076 characters, which is typical for such announcements and not a full report or regulatory filing.
2025-10-28 Chinese
关于召开2025年第二次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2025 second extraordinary general meeting (临时股东会) of the company 拓新药业集团股份有限公司. It includes information about the meeting date, voting procedures (including cumulative voting for independent directors), registration details, and attachments such as proxy forms and voting instructions. There is no financial data, earnings information, or audit content. It is not a report but a formal announcement and invitation to shareholders to attend and vote at the meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2025-10-28 Chinese
第五届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the eighth meeting of the fifth board of directors of the company. It includes details about the meeting's convening, attendance, and voting results on various agenda items such as approval of the third quarter report, resignation and election of independent directors, approval of investment to establish a subsidiary, and the proposal to convene a shareholders' meeting. The document does not contain the actual financial report or detailed financial data but rather the board's decisions and meeting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length is short (1786 characters), and it is not a report itself but an announcement of board meeting resolutions.
2025-10-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.